Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 34Head and Neck Neoplasms 13Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Melanoma 12Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 11Colonic Neoplasms 10Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Prostatic Neoplasms 7Lymphoma, Follicular 7Breast Neoplasms, Male 7Unspecified Adult Solid Tumor, Protocol Specific 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 6Carcinoma, Ovarian Epithelial 6Ovarian Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Gliosarcoma 5Glioblastoma 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Oligodendroglioma 4Liver Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Kidney Neoplasms 4

Interventions

Cyclophosphamide 38Paclitaxel 22Epirubicin 21Trastuzumab 20Docetaxel 20Doxorubicin 19Carboplatin 15Radiotherapy 13Taxes 11Filgrastim 11Neoadjuvant Therapy 9Bevacizumab 9Fluorouracil 8pembrolizumab 7Tamoxifen 7Albumin-Bound Paclitaxel 7Capecitabine 6pertuzumab 5Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Lapatinib 5130-nm albumin-bound paclitaxel 5pegfilgrastim 4Granulocyte Colony-Stimulating Factor 4Cisplatin 4Chemotherapy, Adjuvant 4tipifarnib 3eribulin 3Surgical Procedures, Operative 3Specimen Handling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Inflammatory Breast Neoplasms × Immunohistochemistry × Clear all
NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
1,856 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡